![COVID-19 Therapeutic Product Shortages](/en/-/media/diaglobal/images/tiles/308x308/resources/deep-dive/therapeutic-product-shortages-308x308.jpg?la=en&h=308&w=308&hash=DA3BF4F692449D78D3E91F7F31C19F3A)
Experts warn that COVID-19 may present additional threats such as global supply chain disruption.
Want to dig deeper into combatting therapeutic product shortages?
-
Article
From Business Wire: Ford Works With 3M, GE, UAW to Speed Production of Respirators for Healthcare Workers, Ventilators for Coronavirus Patients
Read Now -
Article
From FiercePharma: Manufacturer halts emergency access to COVID-19 contender remdesivir amid 'overwhelming demand'
Read Now -
Article
From BBC: Drug shortage fears as India limits exports
Read Now -
Article
From FiercePharma: Amid frenzy over potential COVID-19 drug, patients see shortages and states fight reckless scripts
Read Now -
Article
From Bloomberg: India to Spend $1.3 Billion to Boost Pharmaceutical Production
Read Now -
Article
From Euractiv: EU industry touts 3D printing as ‘immediate solution’ to COVID-19 shortages
Read Now -
Article
From US News & World Report: Biggest Threat From Coronavirus May Be to Medicine Supply
Read Now
Want to learn more?
Check out the first in this series of DIA DIRECT webinars: COVID-19: Experts from China Speak on Conducting Clinical Trials During the Pandemic
Regulatory Updates
View all Deep Dives-
Article
From FDA: FDA Continues to Facilitate Access to Crucial Medical Products, Including Ventilators
Read Now -
News
From EMA: Addressing the potential impact of novel coronavirus disease (COVID-19) on medicines supply in the EU
Read Now -
Article
From FDA: Investigational COVID-19 Convalescent Plasma - Emergency INDs
Read Now